Nomura Asset Management Co. Ltd. grew its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 10.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 148,594 shares of the company's stock after buying an additional 13,599 shares during the quarter. Nomura Asset Management Co. Ltd. owned 0.07% of DocuSign worth $9,226,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Diversified Trust Co increased its holdings in DocuSign by 17.7% in the 2nd quarter. Diversified Trust Co now owns 13,133 shares of the company's stock valued at $703,000 after purchasing an additional 1,979 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in DocuSign by 55.3% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 8,213 shares of the company's stock worth $439,000 after acquiring an additional 2,925 shares during the period. V Square Quantitative Management LLC grew its position in DocuSign by 25.7% in the second quarter. V Square Quantitative Management LLC now owns 2,847 shares of the company's stock valued at $152,000 after acquiring an additional 582 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of DocuSign by 24.8% during the second quarter. Assenagon Asset Management S.A. now owns 618,118 shares of the company's stock worth $33,069,000 after purchasing an additional 122,992 shares in the last quarter. Finally, Dakota Wealth Management boosted its stake in shares of DocuSign by 0.8% in the second quarter. Dakota Wealth Management now owns 23,022 shares of the company's stock valued at $1,232,000 after purchasing an additional 181 shares during the period. Institutional investors and hedge funds own 77.64% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have commented on DOCU shares. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a report on Friday, December 6th. Bank of America raised their price objective on DocuSign from $60.00 to $68.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Wells Fargo & Company increased their target price on DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. lifted their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Tuesday, December 3rd. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, DocuSign currently has an average rating of "Hold" and an average target price of $92.45.
Get Our Latest Research Report on DOCU
DocuSign Stock Performance
Shares of NASDAQ DOCU traded down $0.23 during midday trading on Thursday, hitting $94.52. The company's stock had a trading volume of 2,548,571 shares, compared to its average volume of 2,987,027. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The firm's fifty day moving average price is $76.80 and its 200-day moving average price is $62.86. The firm has a market cap of $19.19 billion, a P/E ratio of 19.53, a P/E/G ratio of 11.08 and a beta of 0.92.
Insiders Place Their Bets
In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total value of $820,752.54. Following the sale, the insider now directly owns 70,748 shares of the company's stock, valued at $3,923,684.08. This trade represents a 17.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel D. Springer sold 581,588 shares of the business's stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the transaction, the director now directly owns 906,430 shares of the company's stock, valued at approximately $87,959,967.20. This trade represents a 39.08 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 651,184 shares of company stock valued at $60,878,829 over the last quarter. Insiders own 1.66% of the company's stock.
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.